V
Vibrant
Drug-free alternative for sdult patients with chronic idiopathic constipation
About Vibrant
Vibrant Gastro has developed a novel, non-drug treatment for adults suffering from chronic idiopathic constipation (CIC). The company's core product is an orally administered, vibrating capsule that is biocompatible and designed to mechanically stimulate the colon. This approach, termed the Synchronized Activation Method™, aims to improve bowel regularity without the use of pharmaceuticals.
The system operates as a digital therapeutic solution. Patients are prescribed a course of these single-use capsules, which are taken daily. The capsules' pre-programmed vibrations are intended to trigger peristalsis, the natural wave-like muscle contractions that move food through the digestive tract. The treatment is cleared by the U.S. Food and Drug Administration (FDA), positioning it as a medical-grade intervention.
The business model is centered on prescription-based sales within the healthcare system. The target market consists of individuals with CIC who have not found relief from or are seeking alternatives to traditional laxatives and other drug-based treatments. By offering a data-driven, mechanical solution, Vibrant Gastro operates in the medical device and digital health sectors, specifically within the field of gastroenterology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- Newton, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 83.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices
- Sector
- Biotech & Life Sciences, Dietary Supplements, Biotechnology, medical implants, Gastroenterology, Remote Monitoring, Patient Care, Superfood, Chronic Disease
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES E✓Equity / VC | Mar 2021 | $7.5M | $30M | Unorthodox ventures · Sequoia | — |
| SERIES DEquity / VC | Apr 2019 | $0 | — | Tal Ventures | — |
Growth signals
Latest recorded traffic for Vibrant is 10K monthly website visits, down 50% over the last three months. Vibrant's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later2 investors entered at this stage
Tal Ventures
Unorthodox ventures
Other known investors3 additional known investors
Costa Norte Capital
Gefen Capital
Nicolaas Leeuwenburg
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vibrant on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vibrant’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.